Efficacy and safety study to evaluate DX-2930 in preventing agioedema attacks in patients with Type I and Type II heriditary angioedema (HAE)
- Registry ID
- EUCTR2015-003943-20
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE3
- Sponsor
- Dyax Corp., an indirect, wholly-owned subsidiary of Shire plc.
- Start date
- 2016-01-08
- Completion date
- 2017-04-13
- Last update
- 2026-08-16
Conditions
- Hereditary angioedema (HAE)
Summary
To evaluate the efficacy of DX-2930 in preventing HAE attacks
Locations
- , , Germany
- , , UK
- , , Italy
View on source registry